Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
44 studies found for:    "Human T-cell leukemia virus type 1"
Show Display Options
Rank Status Study
1 Unknown  Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1
Condition: HTLV-I Infections
Intervention:
2 Unknown  Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load
Condition: Human T-cell Leukemia Virus Type 1 Infection
Intervention: Drug: Raltegravir
3 Recruiting Raltegravir for HAM/TSP
Condition: HTLV-I Infection
Intervention: Drug: Raltegravir
4 Recruiting Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Condition: HTLV-1
Intervention: Drug: Hu MiK-Beta-1
5 Completed Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial
Condition: HTLV-I-associated Myelopathy
Intervention: Drug: Zidovudine/lamivudine
6 Unknown  Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Tamibarotene
7 Enrolling by invitation Urological Physical Therapy in HTLV-1 With Urinary Symptoms
Conditions: Tropical Spastic Paraparesis;   HTLV-1
Intervention: Procedure: Urological physical therapy
8 Not yet recruiting Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection
Conditions: HTLV-I Infections;   Tropical Spastic Paraparesis
Intervention: Drug: "Raltegravir" and "Zidovudine"
9 Completed Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)
Conditions: HTLV-I Infection;   Spinal Cord Disease;   Tropical Spastic Paraparesis
Intervention: Drug: Recombinant human interferon beta-1a
10 Completed Natural History of HTLV-I Infection: Prospective Follow-up of a Cohort of Blood Donors in Jamaica
Condition: HTLV-I
Intervention:
11 Recruiting Evaluation of Patients With HAM/TSP
Conditions: HTLV-I Infection;   Tropical Spastic Paraparesis
Intervention:
12 Completed Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Condition: HTLV I Associated Myelopathy
Intervention: Drug: ciclosporin
13 Completed A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis
Condition: HTLV-I
Intervention:
14 Completed Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)
Condition: HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)
Intervention: Drug: CHOP-daclizumab
15 Completed Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases
Conditions: HTLV-1;   Tropical Spastic Paraparesis;   Immune System Diseases;   Physical Disability;   Pentoxifylline
Interventions: Drug: Pentoxifylline;   Drug: Placebo
16 Terminated The HAM Infliximab Study
Condition: HTLV-I-associated Myelopathy
Intervention: Drug: Infliximab
17 Recruiting Sensorimotor Exercises in Virtual Reality Platform in Individuals With Human T-lymphotropic Virus
Condition: HTLV-1
Intervention: Other: Video game
18 Terminated Safety and Efficiency Study of Valproic Acid In HAM/TSP
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Valproic Acid
19 Enrolling by invitation Evaluation of InnoLIA HTLV I/II Score
Condition: Human T-Lymphotrophic Virus Type I and/or Type II
Intervention: Device: InnoLIA HTLV I/II Score line immunoassay
20 Completed
Has Results
Anti-Tac for Treatment of Leukemia
Conditions: HTLV-I Infection;   T Cell Leukemia
Intervention: Biological: daclizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.